Filing Flows › Syndax Pharmaceuticals (SNDX) › Recalls, complaints & regulation
Syndax Pharmaceuticals (SNDX): clinical trials
Syndax Pharmaceuticals (SNDX) beyond its filings: 5 active clinical trials.
Syndax Pharmaceuticals' latest quarter
Syndax Pharmaceuticals, Q3 2026: revenue $83.3M (+82% year over year), operating margin -50.3%, net loss $49.4M, operating cash flow −$27.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Syndax Pharmaceuticals have?
5 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.